one power player within
updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
sought strategi expand beyond legaci
retail pharmaci oper becom healthcar servic
compani firm posit major player within
 healthcar ecosystem build top-tier
pharmaci benefit manag one largest pharmaci
retail firm recent announc acquir aetna
move vertic expand oper health insur
firm recent recvi approv regulatroy bodi
deal expect close fairli shortli deal transform
one power player within healthcar space
view strateg move posit oper
standpoint believ new cvs/aetna healthcar
servic behemoth infrastructur sell insur
manag member everi aspect treatment
regimen howev concern may overpay
aetna materi amount given pay almost doubl
believ aetna worth stand-alone basi mean
aetna signific pressur execut
integr minim issu given complex larg
natur entiti believ risk sharehold
valu may impair
new cvs/aetna structur brand-new busi
model uncertainti surround prospect prevent us
rate new firm wide econom moat howev
believ major opportun combin entiti
reduc cost treat insur member
like firm eventu earn cost capit
extend period accordingli believ new
cvs/aetna least possess narrow econom moat
owner largest network retail pharmaci
 asset play key role new entiti new
firm eventu turn retail locat healthcare-hub
member obtain plethora healthcar servic
product hub allow new firm drive
healthcar cost entir membership book low
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
vertic integr busi throughout almost everi
aspect pharmaceut suppli chain dynam make one
premier healthcar firm compani process
billion prescript per year approxim million health insur
member oper one largest mail-ord pharmaci own
network retail pharmaci clinic across firm
recent acquir aetna extend vertic reach
creat one power healthcar player
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fair valu estim solidifi
cost forecast combin entiti believ
synergi new healthcar hub strategi fulli
ramp end explicit forecast earliest
also incorpor capit structur assumpt
assum firm use greater portion debt capit
believ firm overpay acquisit
aetna high probabl
sharehold valu destruct result price
pay doubl believ aetna worth
oper standpoint believ
slight neg effect near-term oper margin
result revenu mix shift loss certain client
contract within pbm segment long-term return
invest capit remain highli posit given
confluenc enhanc capit effici increas
pharmaceut purchas volum posit synergi
firm gain wide-moat pbm segment
pbm segment forecast adjust claim increas
five-year compound annual growth rate
oper profit per adjust claim increas
five-year compound-annual-growth-rate explicit forecast built
assumpt client growth increas claim volum
per client retail pharmaci segment forecast
revenu increas revenu compound-annual-growth-rate oper
margin averag includ increas cost
run new healthcar
addit model metric factor
aetna specif solid per-memb growth
decreas member medic cost firm healthcar
hub strategi help lower member treatment expens
addit believ materi leverag
central cost administr underwrit
central cost scale across entir organ
includ aetna acquisit believ revenu
grow compound-annual-growth-rate oper incom grow
compound-annual-growth-rate period
scenario analysi take consider sever
variabl includ effect gener price supplier
price power claim volum pbm oper
effect aetna acquisit addit factor
effect consum discretionari spend upon
retail oper bull case factor less
price profit pressur due regulatori headwind
assum abl exert even negoti leverag
supplier tri contend grow competit
correspondingli factor high-single-digit claim volum
growth firm abl increas client base beyond
base assumpt client steer benefit
oper assum economi grow materi
greater rate recent drive sale
high singl digit final factor near
flawless integr aetna asset drive
scenario fair valu estim increas
bear case assum consolid among
leverag player
addit assum govern regul pressur
price profit greater degre anticip
base case firm retail oper also suffer
greatli scenario assum growth
neg territori fair valu estim decreas
assumpt
believ new cvs/aetna premier healthcar
servic player possess narrow econom moat
new firm strong pbm busi give opportun
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
reformul healthcar two
factor lead us rate new combin firm narrow
believ new busi model develop
cvs/aetna merger drive signific level
econom valu strong narrow moat
perspect complex busi high
level execut need integr could pose
somewhat issu certain aspect merger
fumbl addit creation new busi model
also carri materi level uncertainti
implement new strategi evolv
time give us paus regard long-term
return capit -- prevent us award new
conglomer wide moat nonetheless believ
like new cvs/aetna churn materi
econom profit extend period formul
recent acquir aetna move vertic expand
oper health insur success
execut ambiti strategi
would
transform one power player
within healthcar space analyz oper
merit combin entiti believ new
cvs/aetna possess narrow moat posit moat
drive posit trend believ steadili
strengthen competit advantag
new
cvs/aetna roll healthcar hub strategi heart
new combin narrow moat firm
abil control almost everi aspect healthcar
treatment member key piec strategi
retail locat new entiti plan use
healthcar hub allow member
obtain plethora healthcare-rel servic addit
take advantag two key industri driver supplier
price leverag central cost scale total
adjust claim approxim billion pbm abl
negoti top-tier drug price discount supplier
factor give advantag expand client
base preserv gross margin scale also sourc
competit advantag addit claim
process profit previou
aetna acquisit extend
vertic integr within healthcar space new
firm fundament chang healthcar
provid individu view transact
posit oper standpoint believ new
entiti one power player within
analysi point signific opportun
cvs/aetna improv profit return outlook
busi success drive insur
member lower-cost company-own facil
offset posit tailwind increas
cost firm retail oper given asset
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
current pharmaci retail product current
sold locat gather
servic includ
plan sale expert within hub guid
potenti member determin right insur plan
need
treatment plan consult assist
member determin right cours treatment
health cost perspect
medic product distribut member -- drive
much care home set possibl
treatment member minuteclin exam
diagnost test check-up limit procedur
believ newli develop healthcar hub give
cvs/aetna abil move signific amount
member treatment servic good procedur
costlier hospit physician offic set dynam
ultim allow firm treat member lower
cost basi aetna could stand-alone insur
firm find foot new strategi
member current new becom comfort
new healthcar treatment deliveri model expect
return capit continu increas firm
competit advantag grow stronger
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ocv one largest pbm premier
healthcar servic player process approxim
billion adjust claim give firm
top-tier supplier negoti power scale
opharmaceut spend grow robust rate
next sever year given demograph shift
expans medic insur coverag
current uninsur
owe believ merger aetna make one
power player within entir
headwind pbm price pressur increas
oif supplier success control
product consolid could lose
price power
owe believ overpay aetna base upon
stand-alone valuat manag care player
dynam requir strong integr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
solid financi health given current oper
free cash flow firm healthcare-rel oper
provid solid foundat long-term financi stabil
howev issu signific amount new debt
order acquir aetna firm increas
long-term debt approxim billion push
debt/ebitda ratio time manag state
seek lower debt level move debt/ebitda
ratio back current level time given robust
cash flow produc new cvs/aetna entiti
believ goal reason
believ potenti risk poorli execut merger
integr aetna materi firm highli
complex entiti command signific portion
market share within respect sub-market price
paid acquir aetna requir near flawless
integr effort tough task given
previous mention dynam firm also
face oper risk legaci busi
push greater regul pharmaceut industri
player consum discretionari spend consolid
among supplier partner concert
push certain pharmaceut player creat
price transpar govern could enact
price cap pbm acquisit cost becom greater
result could hurt return firm revenu also
materi tie sale nonpharmaceut product
retail locat product tie
consum discretionari spend downturn
economi would headwind addit
risk player success maintain
price power built firm also face greater
amount systemat risk major rival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
signific portion revenu profit tie
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ stewardship solid
sharehold manag strategi shift firm
toward all-encompass healthcar player
prudent move strategi posit firm
advantag long term cost effici
servic critic healthcar sector
manag also made value-cr
acquisit purchas retail
pharmaci move allow firm expand retail
footprint instantli without major roll-out new store
howev cautiou regard price paid
aetna acquisit believ firm overpay
asset requir highli optim integr
oper given larg size complex natur
firm tough task believ
threat sharehold valu destruct result
repres date owner name posit common share held report holder issuer
fidel manag research compani
america corpor
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
remain track close
report solid quarter reiter
fair valu estim narrow-moat pbm firm
report robust increas revenu segment
effort becom prefer pharmaci restrict
network drove retail top line good gain client win
client member growth bolster pbm oper
impress also abl expand gross margin
basi point -- driven larg strong gross profit
perform firm pbm oper howev
retail segment produc decreas gross
margin
gener
pharmaceut product order obtain prefer
pharmaci statu sever pbm pharmaci network
addit firm central cost percentag
revenu increas manag state make
invest use fund save recent tax
reduct invest temper
quarter result believ help lay ground
work smoother integr aetna asset
transact close manag state expect close
deal approv five remain state
team feel confid soon receiv approv
remain state final stage
negoti key jurisdict
forc discount
previous state believ aetna
overal strategi signific potenti drive materi
econom profit come decad
combin new cvs/aetna healthcar servic firm
fundament chang healthcar provid
individu ultim view new entiti
healthcar servic behemoth infrastructur sell
insur manage/treat member everi aspect
healthcar treatment regimen lower cost
perspect capabl key asset
servic member chronic recur medic
issu -- especi key medicar insur cohort
firm abl leverag signific retail
footprint power pbm better control
cost treat patient firm also abl
leverag aetna larg insur membership book solid
underwrit plan design capabl sale
market expertis believ combin
oper give new cvs/aetna entiti key
advantag bring cost treat tradit
aetna merger remain track aug
lot digest second quarter
believ posit quarterli result firm rigor
defens pharmaci benefit manag busi
encourag updat relat
propos aetna
acquisit reinforc posit outlook healthcar
servic conglomer reiter fair valu
estim incorpor aetna acquisit
narrow moat rate combin entiti consid
signific discount equiti current trade fair
valu estim believ investor opportun
acquir share strong healthcar servic firm
advantag price firm report decent increas
revenu segment effort becom prefer
pharmaci restrict network drove solid retail pharmaci
prescript volum good gain client win client
member growth bolster pbm oper
manag provid vigor defens pbm model
especi brand drug manufactur critic
rebat manag emphas rebat drive
brand drug price brand drug categori littl
competit experi price increas faster clip
categori uncompetit market also
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
carri rebat well brand treatment area
multipl manufacturers/opt agre
manag regard assess believ
abl produc signific client valu econom
profit long term manag also disclos
expect pass approxim
rebat client rebat constitut
approxim million adjust earn
applaud manag detail clariti surround
rebat believ figur highlight valu pbm
bring client misinform
permeat market regard pbm busi model
manag provid great deal commentari
regard acquisit aetna said substanti
number state approv deal
approv expect current quarter feder
regulatori review deal remain track
expect transact close end firm
also said make major progress prepar
upcom integr formul execut
manag team help lead effort view
transact posit believ new entiti
one power player healthcar
believ aetna overal strategi signific
potenti drive materi econom profit come
decad combin new cvs-aetna
healthcar servic firm fundament chang
healthcar provid individu ultim
view new entiti healthcar servic behemoth
infrastructur sell insur manage/treat
member everi aspect healthcar treatment
regimen lower cost
perspect capabl key asset
servic member chronic recur medic
issu -- especi key medicar insur cohort
firm abl leverag signific retail
footprint power pbm better control
cost treat patient firm also abl
leverag aetna larg insur membership book solid
underwrit plan design capabl sale
market expertis believ combin
oper give new cvs-aetna entiti key
advantag bring cost treat tradit
detail analysi cvs-aetna merger
includ breakdown competit dynam
drive deal along moat valuat analysi
new healthcar servic entiti pleas see recent
report creation new busi model cvs-
aetna merger moatworthi chang way
despit amazon acquisit pillpack market
june amazon announc purchas mail-ord
pharmaci start-up pillpack move give amazon
foothold within pharmaceut suppli chain
logic step on-line conglomer make
believ retail pharmaci go easiest
segment pharmaceut suppli chain amazon
enter howev also believ still tough
firm creat major disrupt within healthcar
space given insur dynam drive market
perspect new competitor need deal
larg power custom despit
market particip believ true end custom
pharmaceut space consum drug
rather insurer/employer/govern pay
health benefit consum accordingli expertis
need profit navig space preclud easi
opportun new entrant believ current
downward stock price move fear new disrupt
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
major pharma supply-chain player make difficult
price competit
access global suppli drug requir
viabl player within pbm pharma wholes
retail pharmaci space access everi legitim drug
requir due variabl demand health
insur product viabl pharma player need abl
access plethora drug
manufactur across world level access
achiev major drug market servic player
new entrant reach level
option clear major drug benefit provid
seller purchas pharmaceut
detail analysi competit dynam
pharmaceut space amazon podeti disrupt
pleas see report sell drug easier said done
moati pharma channel
competit drug space creat opportun
investor acquir solid moati firm drug wholesal
pbm industri discount
perspect three key variabl
overlook market particip
stakehold analyz potenti new meaning
competit within pharmaceut market
true custom along chain busi
provid health benefit consum provid
health benefit make almost decis regard drug
pharmaci access busi also sourc suppli
drug partnership togeth b-to-b market
develop use drug health insur
base treat medic ailment consum demand
cash pay market estim less
prescript paid consum directli cash-
pay basi without insur dynam would take
mani consumer-bas compani built
core-compet get involv
pharmaceut space
price pharmaceut
drug price high-profil issu engulf
pharmaceut space percept new
entrant particular amazon instantli enter space
cut price drug product howev actual
price drug alreadi low given massiv amount
buy power pbm drug wholesal retail
pharmaci accumul new entrant would hold
minuscul amount purchas power compar
massiv joint sourc ventur
develop last hand year thu level
gener drug discount brand drug rebat new
entrant could command would pale comparison
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
